Literature DB >> 3306095

Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes.

R A Ward, R L Wathen, T E Williams, G B Harding.   

Abstract

We compared the effects of dialysate composition on changes in intermediary metabolites, acid-base balance, and potassium removal during hemodialysis. Patients were dialyzed against dialysates containing acetate or bicarbonate, each with or without glucose, in a four-way cross-over study. Dialysates containing acetate were associated with significant perturbations in intermediary metabolism, including increases in blood citrate, acetoacetate and beta-hydroxybutyrate and a decrease in pyruvate. In contrast, bicarbonate-containing dialysates caused minimal perturbations in intermediary metabolism. Addition of glucose to the dialysate decreased the changes in intermediary metabolites; however, the magnitude of this effect was less than that observed for the change from acetate to bicarbonate. Use of acetate also resulted in lower post-dialysis blood-concentrations of base equivalents than obtained with bicarbonate; this difference was unaffected by the presence or absence of glucose. Although pre- and post-dialysis potassium concentrations were unaffected by the dialysate formulation, total potassium removal was significantly greater when glucose was omitted from the dialysate. Our results suggest that both bicarbonate and glucose should be included in the dialysate, particularly for those patients whose capacity for metabolism may be limited because of highly efficient dialysis, intercurrent illness, or starvation. However, addition of glucose to the dialysate may require a reduction in dialysate potassium to maintain proper potassium homeostasis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306095     DOI: 10.1038/ki.1987.182

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

Review 1.  Correction of chronic metabolic acidosis for chronic kidney disease patients.

Authors:  P Roderick; N S Willis; S Blakeley; C Jones; C Tomson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 2.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

Review 3.  Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5).

Authors:  Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

4.  [Modification of gas exchange and metabolism by various hemodialysis procedures].

Authors:  S Grosser; G Kreymann; S Meierling; W Daerr; A Raedler; H Greten
Journal:  Klin Wochenschr       Date:  1990-08-17

5.  Intradialytic acid-base changes and organic anion production during high versus low bicarbonate hemodialysis.

Authors:  Sarah Park; William Paredes; Matthew Custodio; Narender Goel; Deepak Sapkota; Anusha Bandla; Robert I Lynn; Suman M Reddy; Thomas H Hostetter; Matthew K Abramowitz
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-20

6.  Hemodialysis: core curriculum 2014.

Authors:  Thomas A Golper; Rachel Fissell; William H Fissell; P Matthew Hartle; M Lee Sanders; Gerald Schulman
Journal:  Am J Kidney Dis       Date:  2013-11-19       Impact factor: 8.860

Review 7.  Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia.

Authors:  Markus Pirklbauer
Journal:  Hemodial Int       Date:  2020-05-20       Impact factor: 1.812

Review 8.  Optimizing haemodialysate composition.

Authors:  Francesco Locatelli; Vincenzo La Milia; Leano Violo; Lucia Del Vecchio; Salvatore Di Filippo
Journal:  Clin Kidney J       Date:  2015-08-08

9.  A neglected issue in dialysis practice: haemodialysate.

Authors:  Carlo Basile; Carlo Lomonte
Journal:  Clin Kidney J       Date:  2015-05-28

10.  The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.

Authors:  William B Smith; Sandy Gibson; George E Newman; Kendra S Hendon; Margarita Askelson; James Zhao; Jamil Hantash; Brigid Flanagan; John W Larkin; Len A Usvyat; Ravi I Thadhani; Franklin W Maddux
Journal:  BMC Nephrol       Date:  2017-08-29       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.